Investors 2019-05-28T11:21:31-05:00

Investors

Medibio (ASX: MEB) (OTCQB: MDBIF) is a health technology company pioneering the use of objective measures to aid in the early detection and screening of mental health conditions. Through our Corporate Health product, we offer mental well-being solutions for businesses and we are developing products to serve the healthcare provider market. The company was founded in Australia, with offices located in Melbourne (Vic) and U.S. offices in Minneapolis, MN. 

Medibio Highlights

  • Restructured board and key management
  • New controls in place to reduce cash burn
  • Commercial launch of corporate well-being product, ilumen™
  • Strengthened regulatory path
  • Multiple use cases for our technology platform
  • Strong potential in an underserved market

Shareholder Services

Investors may find additional information on Medibio stock, including real-time quotes, announcements, filings, and history, at the Australian Stock Exchange (www.asx.com.au) and OTC Markets (www.otcmarkets.com). The Medibio share registry is maintained by Computershare, where shareholders can access information about shareholding.

Contacts

U.S.  Investor and Media Enquiries:

Australian Investor Enquiries:

NWR Communications:
peter@nwrcommunications.com.au
T: +61 (0) 412 036 231

Latest Investor Deck

DOWNLOAD

AUS Investor Inquiries

Contact Us